Dermal Therapy ramps up marketing after $150m acquisition with biggest campaign yet

The campaign marks Dermal Therapy's largest marketing investment to date and comes just weeks after Prestige Consumer Healthcare completed its acquisition of LaCorium Health, the Australian company behind Dermal Therapy, Flexitol and Crampeze. SEE MORE: Dermal Therapy builds global skincare challenger"What started as a simple, powerful truth – people want a product that works – has become the heartbeat of our brand," said Ellie Taylor, head of marketing at Dermal Therapy. Dermal Therapy has again partnered with independent media agency Strat to deliver the campaign across Australia and New Zealand. "With over 1,000 sites across two countries, we're delivering Dermal Therapy at a scale that reflects just how much the brand has grown. The announcement follows Prestige Consumer Healthcare's acquisition of LaCorium Health, completed on 1 July.